Synovis Life Technologies
Contact Us
Business
Development
Investor
Information
Synovis Surgical
Innovations
Synovis Micro
Companies Alliance
Corporate Overview
Webcast ImageWebcast
Q3 2009 Synovis Life Technologies, Inc. Earnings Conference Call (Replay)
09/02/09 at 10:00 a.m. CT
Q3 2009 Synovis Life Technologies, Inc. Earnings Conference Call
Wednesday, September 2, 2009 10:00 a.m. CT  
Webcast PresentationHelp Help
Listen to the Webcast in Windows Media Player Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Synovis Life Technologies, Inc. at Oppenheimer & Co. Healthcare Conference (Replay)
11/03/09 at 4:30 p.m. ET
Synovis Life Technologies, Inc. at Oppenheimer & Co. Healthcare Conference
Tuesday, November 3, 2009 4:30 p.m. ET  
Webcast PresentationHelp Help
Listen to the Webcast in Windows Media Player Listen to the Webcast in Real Player Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Q4 2009 Synovis Life Technologies, Inc. Earnings Conference Call (Live)
12/02/09 at 10:00 a.m. CT
Q4 2009 Synovis Life Technologies, Inc. Earnings Conference Call
Wednesday, December 2, 2009 11:00 a.m. ET  
Webcast PresentationHelp Help
Listen to the Webcast in Windows Media Player Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Featured Report
DateTitle
09/22/09
Download Documentation UBS Global Life Sciences Conference Presentation
Get help downloading or viewing the above file types
Corporate Profile

Synovis Life Technologies, Inc. (NASDAQ:SYNO), a diversified medical device company, develops, manufactures and markets medical devices for the surgical treatment of disease. Our products include implantable biomaterials for soft tissue repair, devices for microsurgery and surgical tools – all designed to reduce risks and facilitate critical surgeries, leading to better patient outcomes and/or lower costs.

Stock Quote
SYNO (Common Stock)
ExchangeNASDAQ GM (US Dollar)
Price$11.99
Change (%) Stock is Up 0.03 (0.25%)
Volume84,500
Data as of 11/20/09 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle
11/16/09Synovis Life Technologies to Webcast Fiscal Fourth-Quarter and Full-Year Earnings Conference Call Wednesday, Dec. 2
Live Webcast at 10 a.m. CT ST. PAUL, Minn.--(BUSINESS WIRE)--Nov. 16, 2009-- Synovis Life Technologies, Inc., (NASDAQ: SYNO) will host a live webcast of its fiscal fourth-quarter and full-year conference call on Wednesday, Dec. 2, 2009, at 10 a.m. CT. Synovis President and Chief Executive Officer Richard Kramp and Chief Financial Officer Brett Reynolds will discuss the company’s results for the fiscal fourth quarter and full ye... 
10/29/09Synovis Life Technologies to Present at Oppenheimer 20th Annual Healthcare Conference November 3
Live Webcast at 3:30 p.m. CT (4:30 p.m. ET) ST. PAUL, Minn.--(BUSINESS WIRE)--Oct. 29, 2009-- Synovis Life Technologies, Inc. (Nasdaq: SYNO), a leading biomaterial and surgical products company, will present at the Oppenheimer 20th Annual Healthcare Conference at 3:30 p.m. CT (4:30 p.m. ET) on Tuesday, Nov. 3, 2009, at the Waldorf Astoria Hotel in New York City. Richard W. Kramp, president and chief executive officer, and Brett A. Reynolds,... 
10/26/09Synovis Life Technologies Sells Its Auction Rate Securities
Company Sells Auction Rate Securities for $7.65 Million; Will Record a $2.75 Million Pre-tax Gain in the Fiscal Fourth Quarter ST. PAUL, Minn.--(BUSINESS WIRE)--Oct. 26, 2009-- Synovis Life Technologies, Inc. (Nasdaq: SYNO), a leading biomaterial and surgical products company, today announced that it has sold its portfolio of auction rate securities for $7.65 million in cash. The company’s auction rate securities portfolio h... 
10/22/09Synovis Life Technologies Receives CE Mark Approval for the Use of Veritas(R) Collagen Matrix in Hernia Repair and Breast Reconstruction
Company Will Launch Proprietary Soft Tissue Repair Product Into the European Hernia Repair and Breast Reconstruction Markets ST. PAUL, Minn.--(BUSINESS WIRE)--Oct. 22, 2009-- Synovis Life Technologies, Inc. (Nasdaq: SYNO), a leading biomaterial and surgical products company, has received CE Mark approval for its Veritas® Collagen Matrix, allowing the company to sell Veritas in the European hernia repair and breast reconstruction markets. ... 
Upcoming EventsMore >>
DateTitle
12/02/09 11:00 a.m. ET
Q4 2009 Synovis Life Technologies, Inc. Earnings Conference Call
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Synovis Life Technologies, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
 
Copyright © 2008 MarketWatch, Inc. All rights reserved. Please see our Terms of Use.
Designed and powered by Dow Jones Client Solutions
Intraday data provided by Interactive Data Real Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data.

Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | Financial Tear Sheet Financial Tear Sheet
©2009 Copyright Synovis Surgical Innovations. All rights reserved. Privacy.